Andrew Aronsohn to United States Food and Drug Administration
This is a "connection" page, showing publications Andrew Aronsohn has written about United States Food and Drug Administration.
Connection Strength
0.211
-
Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus. Hepatology. 2014 May; 59(5):1688-91.
Score: 0.115
-
Distributive justice and the arrival of direct-acting antivirals: who should be first in line? Hepatology. 2011 Jun; 53(6):1789-91.
Score: 0.095